100
Views
20
CrossRef citations to date
0
Altmetric
Drug Evaluation

Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy

, &
Pages 1105-1113 | Published online: 12 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lynne Braidwood, Sheila V Graham, Alex Graham & Joe Conner. (2013) Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs. Oncolytic Virotherapy 2, pages 57-74.
Read now

Articles from other publishers (19)

Shu-Jin Li & Zhi-Jun Sun. (2022) Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead. Cancer Letters, pages 215937.
Crossref
Kiira Kalke, Julius Orpana, Tuomas Lasanen, Olaya Esparta, Liisa M. Lund, Fanny Frejborg, Tytti Vuorinen, Henrik Paavilainen & Veijo Hukkanen. (2022) The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1. Viruses 14:6, pages 1290.
Crossref
Ilse Hernandez-Aguirre & Kevin A. Cassady. 2022. Cancer Immunology and Immunotherapy. Cancer Immunology and Immunotherapy 375 437 .
Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza & Samuel D. Rabkin. (2021) In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV. Viruses 13:9, pages 1740.
Crossref
Ifeanyi Kingsley Uche, Konstantin G. Kousoulas & Paul J. F. Rider. (2021) The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment. Viruses 13:7, pages 1200.
Crossref
Marilin Koch, Sean Lawler & E. Chiocca. (2020) HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials. Cancers 12:12, pages 3514.
Crossref
Dmitry V. Chouljenko, Jun Ding, I-Fang Lee, Yanal M. Murad, Xuexian Bu, Guoyu Liu, Zahid Delwar, Yi Sun, Sheng Yu, Ismael Samudio, Ronghua Zhao & William Wei-Guo Jia. (2020) Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes. Biomedicines 8:11, pages 484.
Crossref
Shyambabu Chaurasiya, Yuman Fong & Susanne G. Warner. (2020) Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges. Cancers 12:6, pages 1699.
Crossref
Lizhi Li, Shixin Liu, Duoduo Han, Bin Tang & Jian Ma. (2020) Delivery and Biosafety of Oncolytic Virotherapy. Frontiers in Oncology 10.
Crossref
Hong-My Nguyen, Kirsten Guz-Montgomery & Dipongkor Saha. (2020) Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy. Cells 9:2, pages 400.
Crossref
Chad R. Irwin, Mary M. Hitt & David H. Evans. (2017) Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses. Frontiers in Oncology 7.
Crossref
JIA WAN, XIANGHONG ZHANG, TANG LIU & XIANGSHENG ZHANG. (2016) Strategies and developments of immunotherapies in osteosarcoma. Oncology Letters 11:1, pages 511-520.
Crossref
Cole Peters & Samuel D Rabkin. (2015) Designing herpes viruses as oncolytics. Molecular Therapy - Oncolytics 2, pages 15010.
Crossref
Vincenzo Cerullo, Kilian Guse, Markus Vähä‐Koskela & Akseli Hemminki. 2014. Cancer Gene Therapy by Viral and Non‐viral Vectors. Cancer Gene Therapy by Viral and Non‐viral Vectors 1 20 .
ShangLong Liu, MeiHua Dai, Lei You & YuPei Zhao. (2013) Advance in herpes simplex viruses for cancer therapy. Science China Life Sciences 56:4, pages 298-305.
Crossref
Daniel Y. SzeAndrei H. IagaruSanjiv S. GambhirHans A. De HaanTony R. Reid. (2012) Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [ 18 F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography . Human Gene Therapy 23:1, pages 91-97.
Crossref
Jason D. Walker, Inder Sehgal & Konstantin G. Kousoulas. (2011) Oncolytic Herpes Simplex Virus 1 Encoding 15-Prostaglandin Dehydrogenase Mitigates Immune Suppression and Reduces Ectopic Primary and Metastatic Breast Cancer in Mice. Journal of Virology 85:14, pages 7363-7371.
Crossref
Sunil K. GeevargheseDavid A. GellerHans A. de HaanMarkus HörerAnette E. KnollAxel MeschederJohn NemunaitisTony R. ReidDaniel Y. SzeKenneth K. TanabeHoda Tawfik. (2010) Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver. Human Gene Therapy 21:9, pages 1119-1128.
Crossref
Arturo R. Maldonado, Chuck Klanke, Anil G. Jegga, Bruce J. Aronow, Yonatan Y. Mahller, Timothy P. Cripe & Timothy M. Crombleholme. (2010) Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors. The Journal of Gene Medicine 12:7, pages 613-623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.